Anna Tzortzi1, Stephanie Teloniatis2, George Matiampa3, Gerasimos Bakelas3, Chara Tzavara4, Vergina Konstantina Vyzikidou1, Constantine Vardavas1, Panagiotis Behrakis5, Esteve Fernandez6. 1. "George D. Behrakis Research Lab" Hellenic Cancer Society, Athens, Greece; Institute of Public Health at the American College of Greece, Athens, Greece. 2. "George D. Behrakis Research Lab" Hellenic Cancer Society, Athens, Greece. Electronic address: steloniatis@gmail.com. 3. "George D. Behrakis Research Lab" Hellenic Cancer Society, Athens, Greece. 4. Department of Hygiene, Epidemiology and Medical Statistics, National and Kapodistrian University of Athens, Medical School, Athens, Greece. 5. "George D. Behrakis Research Lab" Hellenic Cancer Society, Athens, Greece; Institute of Public Health at the American College of Greece, Athens, Greece; Biomedical Research Foundation, Academy of Athens, Athens, Greece; Athens Medical Centre, Athens, Greece. 6. Tobacco Control Unit, Department of Cancer Epidemiology and Prevention, Catalan Institute of Oncology (ICO), L'Hospitalet de Llobregat, Barcelona, Spain; Tobacco Control Unit, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat (Barcelona), Spain; Department of Clinical Sciences, School of Medicine and Health Sciences, Campus of Bellvitge, University of Barcelona, Spain.
Abstract
AIM: The current study examined symptoms of irritation reported by non-smokers passively exposed to e-cigarette aerosols and their timing and association with the concentrations of volatile organic compounds (VOCs) produced. METHODS: 40 healthy non-smoking adults were exposed to e-cigarette aerosols for 30 min in a 35 m3 room. Second-hand e-cigarette aerosol (SHA) was produced by an experienced e-cigarette user using a standardized topography and two resistance settings (exposure 0.5 Ohm and 1.5 Ohm), in addition to a control session (no emissions). PM2.5 and PM1.0 were continuously measured over the duration of exposure, while Volatile Organic Compounds (VOCs) were recorded at 0, 15 and 30 min (t0, t15 and t30) of exposure. Each participant completed an irritation questionnaire at t0, t15, t30 of exposure and t60 (30 min post-exposure) on ocular, nasal, throat-respiratory symptoms of irritation and general complaints. Kruskal-Wallis H test for PM comparisons, repeated measures ANOVA for VOCs and Generalized Estimating Equations for symptoms of irritation and association with VOCs were used for statistical analysis. RESULTS: 20 males and 20 females, with a mean age of 24.6 years (SD = 4.3) and exhaled CO < 7 ppm participated. PM concentrations in both experimental sessions were higher than the Control (p < 0.001). The most commonly reported symptoms were burning, dryness, sore throat, cough, breathlessness and headache. During both experimental sessions, ocular, nasal, throat-respiratory symptoms and general complaints increased significantly (p < 0.05). Ocular and nasal symptoms returned to baseline by t60 (p > 0.05) while throat-respiratory symptoms were still significantly higher at t60 (p = 0.044). VOCs were significantly associated with reported nasal and throat-respiratory symptoms in both experimental sessions (p < 0.05). CONCLUSION: A 30-min exposure to SHA provoked symptoms of sensory irritation and general complaints that lasted up to 30 min after the exposure and were positively associated with the concentrations of the VOC mixture emitted.
AIM: The current study examined symptoms of irritation reported by non-smokers passively exposed to e-cigarette aerosols and their timing and association with the concentrations of volatile organic compounds (VOCs) produced. METHODS: 40 healthy non-smoking adults were exposed to e-cigarette aerosols for 30 min in a 35 m3 room. Second-hand e-cigarette aerosol (SHA) was produced by an experienced e-cigarette user using a standardized topography and two resistance settings (exposure 0.5 Ohm and 1.5 Ohm), in addition to a control session (no emissions). PM2.5 and PM1.0 were continuously measured over the duration of exposure, while Volatile Organic Compounds (VOCs) were recorded at 0, 15 and 30 min (t0, t15 and t30) of exposure. Each participant completed an irritation questionnaire at t0, t15, t30 of exposure and t60 (30 min post-exposure) on ocular, nasal, throat-respiratory symptoms of irritation and general complaints. Kruskal-Wallis H test for PM comparisons, repeated measures ANOVA for VOCs and Generalized Estimating Equations for symptoms of irritation and association with VOCs were used for statistical analysis. RESULTS: 20 males and 20 females, with a mean age of 24.6 years (SD = 4.3) and exhaled CO < 7 ppm participated. PM concentrations in both experimental sessions were higher than the Control (p < 0.001). The most commonly reported symptoms were burning, dryness, sore throat, cough, breathlessness and headache. During both experimental sessions, ocular, nasal, throat-respiratory symptoms and general complaints increased significantly (p < 0.05). Ocular and nasal symptoms returned to baseline by t60 (p > 0.05) while throat-respiratory symptoms were still significantly higher at t60 (p = 0.044). VOCs were significantly associated with reported nasal and throat-respiratory symptoms in both experimental sessions (p < 0.05). CONCLUSION: A 30-min exposure to SHA provoked symptoms of sensory irritation and general complaints that lasted up to 30 min after the exposure and were positively associated with the concentrations of the VOC mixture emitted.
Authors: Terry Gordon; Emma Karey; Meghan E Rebuli; Yael-Natalie H Escobar; Ilona Jaspers; Lung Chi Chen Journal: Annu Rev Pharmacol Toxicol Date: 2021-09-23 Impact factor: 16.459
Authors: Zachery R Jarrell; Matthew Ryan Smith; Xiaojia He; Michael Orr; Dean P Jones; Young-Mi Go Journal: Toxicol Sci Date: 2021-07-16 Impact factor: 4.849
Authors: Mariangela Peruzzi; Elena Cavarretta; Giacomo Frati; Roberto Carnevale; Fabio Miraldi; Giuseppe Biondi-Zoccai; Sebastiano Sciarretta; Francesco Versaci; Vittoria Cammalleri; Pasquale Avino; Carmela Protano; Matteo Vitali Journal: Int J Environ Res Public Health Date: 2020-08-19 Impact factor: 3.390
Authors: Evangelia Demou; Ruaraidh Dobson; Helen Sweeting; Ashley Brown; Scott Sidwell; Rachel O'Donnell; Kate Hunt; Sean Semple Journal: Ann Work Expo Health Date: 2020-11-16 Impact factor: 2.779